Example: Heart Attack

Search clinical trials for: Antiparkinson Agents

Total 1041 results

NCT03000569

Completed

A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease

Conditions: Parkinson Disease
NCT01960842

Completed

A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications

Conditions: Advanced Parkinson's Disease
NCT02082249

Completed

An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications

Conditions: Advanced Parkinson's Disease
NCT00617019

Completed

Impulse Control Disorders in Parkinson's Patients Treated With Pramipexole and Other Agents (DOMINION Study)

Conditions: Parkinson Disease
NCT02799381

Completed

A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)

Conditions: Parkinson's Disease (PD)
NCT02236741

Completed

The Use of Pramipexole and Other Dopamine Agonists and the Risks of Heart Failure and Pneumonia

Conditions: Heart Failure
NCT02347059

Unknown status

L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

Conditions: Parkinson's Disease
NCT02812147

Active, not recruiting

Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease

Conditions: Parkinson Disease
NCT04510922

Recruiting

Lundbeck TOMs Orthostatic Hypotension

Conditions: Orthostatic Hypotension; Idiopathic Parkinson Disease
NCT03446807

Not yet recruiting

Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism

Conditions: Parkinson Disease; Multiple System Atrophy; Progressive Supranuclear Palsy
NCT03602014

Recruiting

Dose Response to the Norepinephrine Precursor Droxidopa in Hypotensive Individuals With Spinal Cord Injury

Conditions: Hypotension, Orthostatic; Hypotension; Spinal Cord Injuries
NCT03567447

Recruiting

Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)

Conditions: Parkinson Disease; Falls Patient
NCT02624310

Withdrawn

A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis

Conditions: HSAN Type IV
NCT03229174

Recruiting

Brain Perfusion & Oxygenation in Parkinson's Disease With NOH

Conditions: Parkinson Disease; Neurogenic Orthostatic Hypotension
NCT03173781

Completed

Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease

Conditions: Parkinson's Disease
NCT03034564

Unknown status

A Randomized, Double-Blind, Placebo-Controlled Study of Droxidopa for Fatigue in Parkinson's Disease

Conditions: Parkinson Disease; Fatigue; Parkinsonism
NCT02852213

Recruiting

A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients

Conditions: AADC Deficiency
NCT02586623

Recruiting

Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension

Conditions: Symptomatic Neurogenic Orthostatic Hypotension
NCT02066571

Unknown status

Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease

Conditions: Parkinson's Disease; Freezing of Gait; Cognitive Ability, General
NCT01612078

Terminated

Phase 3 Study to Evaluate the Efficacy and Safety of Droxidopa on Orthostatic Hypotension Treatment in Hemodialysis Patients

Conditions: Orthostatic Hypotension
NCT02558972

Recruiting

Northera Improves Postural Tachycardia Syndrome (POTS) and Postural Vasovagal Syncope (VVS)

Conditions: Postural Tachycardia Syndrome (POTS); Vasovagal Syncope (VVS); Fainting
NCT00738062

Completed

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Conditions: Neurogenic Orthostatic Hypotension; Non-Diabetic Autonomic Neuropathy; Multiple System Atrophy; Dopamine Beta Hydroxylase Deficiency
NCT02071459

Completed

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

Conditions: Multiple System Atrophy
NCT04469959

Not yet recruiting

Dopaminergic Dysfunction in Late-Life Depression

Conditions: Late Life Depression; Cognitive Decline; Depressive Disorder, Treatment-Resistant; Levodopa; Gait Impairment
NCT01468259

Withdrawn

A Multi-Center, Open-Label Study

Conditions: Renal Disease; End Stage Renal Disease